FARESTON (toremifene citrate) tablet [GTx, Inc.] - DailyMed: About ...
FARESTON (toremifene citrate) Tablets for oral administration each contain 88.5 mg of toremifene citrate, which is equivalent to 60 mg toremifene. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8888...
|
Toremifene citrate (Fareston).
Toremifene citrate (Fareston). Gerken P. Kansas City Cancer Center-South, Missouri, USA. Mesh Terms: Antineoplastic Agents, Hormonal/pharmacology ...
http://www.ncbi.nlm.nih.gov/pubmed/15565747...
|
Fareston (toremifene citrate) - US Food and Drug Administration ...
is promoting its product, Fareston, in violation of the Federal Food, Drug, and Cosmetic ... and median survival for Fareston versus tamoxifen patients. ...
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulat...
|
Toremifene - Wikipedia, the free encyclopedia
3 Jan 2009 ... Licensed in the United States under the brand name Fareston, toremifene citrate is FDA approved for use in advanced (metastatic) breast ...
http://en.wikipedia.org/wiki/Toremifene...
|
[Hormone therapy of advanced renal cancer with high-dose ...
Toremifene (Fareston)-a novel antiestrogenic drug with a triphenylethylene structure-has been effective in the treatment of postmenopausal breast cancer
...
http://www.ncbi.nlm.nih.gov/pubmed/9064893...
|
Summary of GTX INC /DE/ - Yahoo! Finance
The active pharmaceutical ingredient in FARESTON® is the same as in our toremifene ... Our net loss included FARESTON® net product sales of $759000 and
the ...
http://biz.yahoo.com/e/090511/gtxi10-q.html...
|
Determinants of early distant metastatic disease in elderly ...
METHODS: We analyzed data from 938 patients in the North American Fareston Tamoxifen Adjuvant Trial>or=65 years old to determine predictors of early ...
http://www.ncbi.nlm.nih.gov/pubmed/16920425...
|
GTx, Inc. Reports Second Quarter 2009 Corporate Results - Yahoo ...
10 Aug 2009 ... Revenues included net sales of FARESTON® (toremifene citrate) 60 mg, marketed for the treatment of metastatic breast cancer in ...
http://biz.yahoo.com/bw/090810/20090810005377.html?.v=2...
|
Body mass index influences palpability but not stage of breast ...
BMI was calculated for patients in the North American Fareston and Tamoxifen Adjuvant trial, and was correlated with clinicopathologic factors, ...
http://www.ncbi.nlm.nih.gov/pubmed/17658091...
|
Summary of GTX INC /DE/ - Yahoo! Finance
23 Jan 2009 ... Revenue for the fourth quarter of 2008 included collaboration income of $2.8 million and $242000 of net sales of FARESTON® (toremifene ...
http://biz.yahoo.com/e/090123/gtxi8-k.html...
|
